Interestingly, Homozygous patients with the UGT1A1*28 allele were found to have a heightened susceptibility to neutropenia when administered SG, as indicated by a higher incidence of all-grade neutropenia compared to heterozygous or wild-type individuals. Here, UGT1A1 is linked to neutropenia.